Figure 7.

Platelet counts of patients with chemotherapy-induced thrombocytopenia treated with romiplostim. Median weekly platelet counts for solid tumor patients (n=122, blue) with no predictors of non-response (no PNR); solid tumor patients (n=31, gray) with predictors of non-response (PNR: bone marrow invasion by tumor, prior pelvic irradiation, or prior temozolomide treatment); aggressive lymphoma patients (n=13, red); and myeloma patients (n=7, purple). Data reproduced with permission from Al-Samkari H et al.²⁷